Research Report Initiated on Select Healthcare Equities

LONDON, UK / ACCESSWIRE / June 21, 2016 / ActiveWallSt.com announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Healthcare sector. Companies recently under review include Zoetis, Mallinckrodt, MiMedx, and Tetraphase Pharma. See our complete report on ZTS at:

http://www.activewallst.com/registration-3/?symbol=ZTS

Today, ActiveWallSt.com is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/.

Under the microscope this morning is the Healthcare sector, which continues to present a number of growth opportunities. Let us see how this is affecting some of the big names in the industry. Register with us now for your free membership and more research reports at

http://www.activewallst.com/register/

Let us take a look at the performance of each of the aforementioned companies over the last few trading sessions.

Zoetis Inc. (NYSE: ZTS)

On Monday, shares in Florham Park, New Jersey headquartered Zoetis Inc. recorded a trading volume of 2.54 million shares. The stock ended the day at $46.91, climbing 1.01%. The Company’s shares have gained 1.03% in the last one month and 12.94% over the previous three months. The stock is trading above its 200-day moving average by 5.03%. Furthermore, shares of Zoetis, which engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the U.S. and globally, have a Relative Strength Index (RSI) of 45.84. On June 10th, 2016, research firm Citigroup downgraded the Company’s stock rating from ‘Buy’ to ‘Neutral’.

Mallinckrodt PLC (NYSE: MNK)

Chesterfield, the U.K. based Mallinckrodt PLC’s stock finished yesterday’s session 0.03% lower at $58.01 and with a total volume of 1.57 million shares traded. The Company’s shares are trading below their 50-day moving average by 5.65%. Shares in Mallinckrodt, which develops, manufactures, markets, and distributes specialty pharmaceutical and biopharmaceutical products, and nuclear imaging agents, has an RSI of 37.32. On June 06th, 2016, research firm Goldman initiated a ‘Neutral’ rating, issuing a target price of $73 on the Company’s stock.

MiMedx Group Inc. (NASDAQ: MDXG)

At the closing bell on Monday, shares in Marietta, Georgia headquartered MiMedx Group Inc. gained 2.07%, ending the day at $7.63. The stock recorded a trading volume of 515,801 shares. The Company’s shares have advanced 11.15% in the last one month. The stock is trading 0.70% below its 50-day moving average. Moreover, shares of MiMedx, which develops, processes, and markets patent protected and proprietary regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues, and human skin and bone, have an RSI of 45.20.

Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH)

Watertown, Massachusetts headquartered clinical-stage biopharmaceutical Company, Tetraphase Pharmaceuticals Inc.’s stock ended the day 1.29% higher at $3.94 and with a total volume of 384,771 shares traded. The Company’s shares have gained 7.95% in the last month. The stock is trading 14.88% below its 50-day moving average. Additionally, shares of Tetraphase Pharmaceuticals, which develops various antibiotics for the treatment of serious and life-threatening multidrug-resistant infections, have an RSI of 39.43.

—

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441437